Jess Marden
Boston
Education
Sc.D., social epidemiology, Harvard T.H. Chan School of Public Health; M.P.H., epidemiology and biostatistics, Tufts University School of Medicine; B.A., international relations, Tufts University
Summary of Experience
Dr. Marden specializes in applying tools from epidemiology and biostatistics to health economics and outcomes research (HEOR) questions. She has experience applying novel epidemiologic methods to multiple disease areas, including rare diseases, multiple types of cancer, and neurological and cardiovascular diseases. Her work includes estimating the burden of illness from claims data, prospectively collecting natural history data to inform trial design and the understanding of disease progression, estimating the comparative efficacy of alternative therapies, and analyzing treatment patterns. Prior to joining Analysis Group, Dr. Marden was a postdoctoral research fellow at the Broad Institute of MIT and Harvard.
Selected Publishing
-
Health Care Resource Utilization by Patients with Alagille Syndrome
The Journal of Pediatrics, 2023
2023Ebel NH, Goldstein A, Howard R, Mogul DB, Marden JR, Anderson A, Gaburo K, Kirson N, Rosenthal P
-
Costs of Pediatric Liver Transplantation among Commercially- and Medicaid-Insured Patients with Cholestasis in the United States
Liver Transplantation, 2023
2023Miloh T, Goldstein A, Howard R, Mogul DB, Marden JR, Anderson A, Gaburo K, Kirson N, Rosenthal P
-
Disease Progression Rates in Ambulatory Duchenne Muscular Dystrophy by Steroid Type, Patient Age and Functional Status
Journal of Comparative Effectiveness Research, 2023
2023McDonald CM, Marden JR, Shieh PB, Wong BL, Lane H, Zhang A, Nguyen H, Frean M, Trifillis P, Koladicz K, Signorovitch J
-
Functional and Clinical Outcomes Associated with Steroid Treatment among Non-Ambulatory Patients with Duchenne Muscular Dystrophy1
Journal of Neuromuscular Diseases, 2023
2023McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J
-
Burden of Illness and Treatment Patterns among Patients with Von Willebrand Disease in Us Clinical Practice
Clinical and Applied Thrombosis/Hemostasis, 2023
2023 -
Maralixibat Treatment Response in Alagille Syndrome Is Associated with Improved Health-Related Quality of Life
The Journal of Pediatrics, 2022
2022Kamath BM, Goldstein A, Howard R, Garner W, Vig P, Marden JR, Billmyer E, Anderson A, Kirson N, Jacquemin E, Gonzales E
-
The Economic Burden of Schizophrenia in the United States
Journal of Clinical Psychiatry, 2022
2022Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A, Kirson N, Dembek C
-
Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States
Current Medical Research and Opinion, 2021
2021Saxena K, Marden JR, Carias C, Bhatti A, Patterson-Lomba O, Gomez-Lievano A, Yao L, Chen YT
-
Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes
Journal of Comparative Effectiveness Research, 2021
2021Marden JR, Santos C, Pfister B, Able R, Lane H, Somma M, Zhao J, Signorovitch J, Parsons J, Apkon S
-
Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center
Journal of Comparative Effectiveness Research, 2020
2020Marden JR, Freimark J, Yao Z, Signorovitch J, Tian C, Wong BL
-
Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding
Annals of Epidemiology, 2019
2019Glymour MM, Gibbons LE, Gilsanz P, Gross AL, Mez J, Brewster PW, Marden J, Zahodne LB, Nho K, Hamilton J, Li G, Larson EB, Crane PK